Study finds insignificant differences in various Nicotine Replacement Therpay quit rates!
A study published in the Journal of the American Medical Association found that smoking cessation rates for various nicotine replacement therapies (NRTs) “did not differ significantly at either six months or a year.” The study found that “the nicotine patch, the drug Chantix [varenicline], or a combination of the patch and lozenges all appear to work equally well,” with six month quit rates of 23%, 24%, and 27%, respectively, which declined to 21%, 19%, and 20% after one year.
The study involved more than 1,000 smokers who received counseling and three months of a randomly assigned treatment. The authors noted, however, that more than half of each group stopped participating before completing the 12-week treatment.
